A Randomized Controlled Trial of Omega 3 Fatty Acids in Rosacea Patients with Dry Eye Symptoms
Bhargava R
Published in Current Eye Research
Methodology
Randomized controlled trial of oral omega-3 fatty acid supplementation versus placebo for six months in rosacea patients with dry eye, with OSDI symptom scoring, tear film break-up time and Schirmer testing.
Key Findings
Six months of oral omega-3 supplementation improved dry eye symptom scores, tear break-up time and Schirmer test values in rosacea patients compared with placebo.
Conclusions
Omega-3 supplementation improved dry eye symptoms and signs in rosacea patients.
Limitations
Single-centre design, partly subjective symptom endpoint, no assessment of durability after stopping, and generalisability limited to rosacea-associated dry eye.
Supplements Studied
Rosacea patients with dry eye symptoms have significant improvement in symptoms, MGS, TBUT, and Schirmer score, following dietary intervention with O3FAs for 6 months.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.